Latest News & Features
Big Pharma
Novo Nordisk has bought a University of Bristol spin-out company for $800 million, in a deal which could transform the way diabetes is treated. 20 August 2018
Americas
The US Food and Drug Administration yesterday granted Teva approval for the first generic version of EpiPen, an autoinjector pen used for the emergency treatment of allergic reactions. 17 August 2018
Americas
An addiction treatment facility has accused another organisation of exploiting vulnerable individuals by providing misleading information containing trademarked names on its websites. 16 August 2018
Americas
Pfizer has entered into a multi-year collaboration with immunotherapy company BioNTech to develop messenger ribonucleic acid-based vaccines for influenza. 16 August 2018
Americas
A patent dispute over a generic version of Purdue Pharma’s drug OxyContin (oxycodone), which is used to treat moderate to severe pain, has come to an end. 15 August 2018
Asia-Pacific
Japan-based Astellas Pharma has acquired Quethera, a UK-headquartered gene therapy company focused on developing treatments for ocular disorders. 15 August 2018
Americas
Medical technology company Biocompatibles UK last week withdrew its oppositions to two trademarks applied for by Pfizer, four months after settlement negotiations. 14 August 2018
Americas
AbbVie has taken Sandoz to court over its biosimilar version of Humira (adalimumab), heightening the dispute between the pair. 13 August 2018
Americas
Members of the Pharmaceutical Research and Manufacturers of America last year obtained the highest-ever level of investment for the industry group, recording $71.4 billion of funding in research and development. 13 August 2018
Asia-Pacific
South Korea-based Samsung has revealed plans to commit W25 trillion to pursue new technology in areas including biopharmaceuticals and artificial intelligence. 10 August 2018